Deng, H., Wang, L., Chen, X., Zhang, S., Yi, F., Wei, Y., & Zhang, W. (2020). Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer: A meta-analysis based on randomized controlled trials. Medicine (Baltimore).
Citação norma ChicagoDeng, Huan, Li Wang, Xinling Chen, Shujuan Zhang, Fengming Yi, Yiping Wei, and Wenxiong Zhang. "Erlotinib Plus Tivantinib Versus Erlotinib Alone in Patients With Previously Treated Stage IIIb/IV Non–small-cell Lung Cancer: A Meta-analysis Based On Randomized Controlled Trials." Medicine (Baltimore) 2020.
MLA CitationDeng, Huan, et al. "Erlotinib Plus Tivantinib Versus Erlotinib Alone in Patients With Previously Treated Stage IIIb/IV Non–small-cell Lung Cancer: A Meta-analysis Based On Randomized Controlled Trials." Medicine (Baltimore) 2020.